Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
63.27
+11.98 (23.36%)
At close: Apr 13, 2026, 4:00 PM EDT
62.29
-0.98 (-1.55%)
After-hours: Apr 13, 2026, 7:57 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $4.97 billion as of April 13, 2026. Its market cap has increased by 384.38% in one year.
Market Cap
4.97B
Enterprise Value
4.21B
1-Year Change
384.38%
Ranking
Category
Stock Price
$63.27
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $4.97B, an increase of 4,348.73%. That is a compound annual growth rate of 46.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 4.03B | 58.48% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 5.69B |
| Xenon Pharmaceuticals | 5.59B |
| Caris Life Sciences | 5.40B |
| CRISPR Therapeutics AG | 5.26B |
| Apellis Pharmaceuticals | 5.22B |
| Immunovant | 5.11B |
| Erasca | 5.07B |
| TG Therapeutics | 5.00B |